Login / Signup

Protocol of the EFFORT study: a prospective study of FOLFIRI plus aflibercept as second-line treatment after progression on FOLFOXIRI plus bevacizumab or during maintenance treatment in patients with unresectable/metastatic colorectal cancer.

Hironaga SatakeKoji AndoEiji OkiMototsugu ShimokawaAkitaka MakiyamaHiroshi SaekiAkihito TsujiMasaki Mori
Published in: BMC cancer (2020)
Japan Registry of Clinical Trials jRCTs071190003 . Registered April 18, 2019.
Keyphrases
  • metastatic colorectal cancer
  • clinical trial
  • randomized controlled trial
  • combination therapy
  • radiation therapy
  • replacement therapy
  • rectal cancer
  • liver metastases